Literature DB >> 19357085

Changes in the spinal cord proteome of an amyotrophic lateral sclerosis murine model determined by differential in-gel electrophoresis.

Daniel Bergemalm1, Karin Forsberg, P Andreas Jonsson, Karin S Graffmo, Thomas Brännström, Peter M Andersen, Henrik Antti, Stefan L Marklund.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by loss of motor neurons resulting in progressive paralysis. To date, more than 140 different mutations in the gene encoding CuZn-superoxide dismutase (SOD1) have been associated with ALS. Several transgenic murine models exist in which various mutant SOD1s are expressed. We used DIGE to analyze the changes in the spinal cord proteome induced by expression of the unstable SOD1 truncation mutant G127insTGGG (G127X) in mice. Unlike mutants used in most other models, G127X lacks SOD activity and is present at low levels, thus reducing the risk of overexpression artifacts. The mice were analyzed at their peak body weights just before onset of symptoms. Variable importance plot analysis showed that 420 of 1,800 detected protein spots contributed significantly to the differences between the groups. By MALDI-TOF MS analysis, 54 differentially regulated proteins were identified. One spot was found to be a covalently linked mutant SOD1 dimer, apparently analogous to SOD1-immunoreactive bands migrating at double the molecular weight of SOD1 monomers previously detected in humans and mice carrying mutant SOD1s and in sporadic ALS cases. Analyses of affected functional pathways and the subcellular representation of alterations suggest that the toxicity exerted by mutant SODs induces oxidative stress and affects mitochondria, cellular assembly/organization, and protein degradation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19357085      PMCID: PMC2690489          DOI: 10.1074/mcp.M900046-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  35 in total

1.  The ubiquitin-like protein HUB1 forms SDS-resistant complexes with cellular proteins in the absence of ATP.

Authors:  Jens Lüders; George Pyrowolakis; Stefan Jentsch
Journal:  EMBO Rep       Date:  2003-11-07       Impact factor: 8.807

2.  Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite.

Authors:  J P Crow; J B Sampson; Y Zhuang; J A Thompson; J S Beckman
Journal:  J Neurochem       Date:  1997-11       Impact factor: 5.372

3.  Overloading of stable and exclusion of unstable human superoxide dismutase-1 variants in mitochondria of murine amyotrophic lateral sclerosis models.

Authors:  Daniel Bergemalm; P Andreas Jonsson; Karin S Graffmo; Peter M Andersen; Thomas Brännström; Anna Rehnmark; Stefan L Marklund
Journal:  J Neurosci       Date:  2006-04-19       Impact factor: 6.167

4.  Proteasomal inhibition by misfolded mutant superoxide dismutase 1 induces selective motor neuron death in familial amyotrophic lateral sclerosis.

Authors:  Makoto Urushitani; Junko Kurisu; Kayoko Tsukita; Ryosuke Takahashi
Journal:  J Neurochem       Date:  2002-12       Impact factor: 5.372

5.  Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.

Authors:  D Jaarsma; E D Haasdijk; J A Grashorn; R Hawkins; W van Duijn; H W Verspaget; J London; J C Holstege
Journal:  Neurobiol Dis       Date:  2000-12       Impact factor: 5.996

6.  Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases.

Authors:  Joungil Choi; Allan I Levey; Susan T Weintraub; Howard D Rees; Marla Gearing; Lih-Shen Chin; Lian Li
Journal:  J Biol Chem       Date:  2004-01-13       Impact factor: 5.157

7.  Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction.

Authors:  L J Haverkamp; V Appel; S H Appel
Journal:  Brain       Date:  1995-06       Impact factor: 13.501

8.  Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis.

Authors:  P Andreas Jonsson; Karin Ernhill; Peter M Andersen; Daniel Bergemalm; Thomas Brännström; Ole Gredal; Peter Nilsson; Stefan L Marklund
Journal:  Brain       Date:  2003-10-08       Impact factor: 13.501

9.  Mitochondrial superoxide production and nuclear factor erythroid 2-related factor 2 activation in p75 neurotrophin receptor-induced motor neuron apoptosis.

Authors:  Mariana Pehar; Marcelo R Vargas; Kristine M Robinson; Patricia Cassina; Pablo J Díaz-Amarilla; Tory M Hagen; Rafael Radi; Luis Barbeito; Joseph S Beckman
Journal:  J Neurosci       Date:  2007-07-18       Impact factor: 6.167

10.  Apaf1 mediates apoptosis and mitochondrial damage induced by mutant human SOD1s typical of familial amyotrophic lateral sclerosis.

Authors:  Mauro Cozzolino; Alberto Ferri; Elisabetta Ferraro; Giuseppe Rotilio; Francesco Cecconi; Maria Teresa Carrì
Journal:  Neurobiol Dis       Date:  2005-07-19       Impact factor: 5.996

View more
  8 in total

1.  ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import.

Authors:  Quan Li; Christine Vande Velde; Adrian Israelson; Jing Xie; Aaron O Bailey; Meng-Qui Dong; Seung-Joo Chun; Tamal Roy; Leah Winer; John R Yates; Roderick A Capaldi; Don W Cleveland; Timothy M Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-15       Impact factor: 11.205

2.  Proteins that bind to misfolded mutant superoxide dismutase-1 in spinal cords from transgenic amyotrophic lateral sclerosis (ALS) model mice.

Authors:  Per Zetterström; Karin S Graffmo; Peter M Andersen; Thomas Brännström; Stefan L Marklund
Journal:  J Biol Chem       Date:  2011-04-14       Impact factor: 5.157

3.  Galectin-3 is a candidate biomarker for amyotrophic lateral sclerosis: discovery by a proteomics approach.

Authors:  Jian-Ying Zhou; Leila Afjehi-Sadat; Seneshaw Asress; Duc M Duong; Merit Cudkowicz; Jonathan D Glass; Junmin Peng
Journal:  J Proteome Res       Date:  2010-10-01       Impact factor: 4.466

4.  Cerebrospinal Fluid from Sporadic Amyotrophic Lateral Sclerosis Patients Induces Mitochondrial and Lysosomal Dysfunction.

Authors:  Aparna Sharma; Anu Mary Varghese; Kalyan Vijaylakshmi; Rajendrarao Sumitha; V K Prasanna; S Shruthi; B K Chandrasekhar Sagar; Keshava K Datta; Harsha Gowda; Atchayaram Nalini; Phalguni Anand Alladi; Rita Christopher; Talakad N Sathyaprabha; Trichur R Raju; M M Srinivas Bharath
Journal:  Neurochem Res       Date:  2015-12-08       Impact factor: 3.996

5.  Molecular signatures of amyotrophic lateral sclerosis disease progression in hind and forelimb muscles of an SOD1(G93A) mouse model.

Authors:  Daniele Capitanio; Michele Vasso; Antonia Ratti; Giuliano Grignaschi; Manuela Volta; Manuela Moriggi; Cristina Daleno; Caterina Bendotti; Vincenzo Silani; Cecilia Gelfi
Journal:  Antioxid Redox Signal       Date:  2012-06-13       Impact factor: 8.401

Review 6.  SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments.

Authors:  Peter I Joyce; Pietro Fratta; Elizabeth M C Fisher; Abraham Acevedo-Arozena
Journal:  Mamm Genome       Date:  2011-06-26       Impact factor: 2.957

7.  Altered gene expression, mitochondrial damage and oxidative stress: converging routes in motor neuron degeneration.

Authors:  Luisa Rossi; Cristiana Valle; Maria Teresa Carrì
Journal:  Int J Cell Biol       Date:  2012-05-17

8.  Multi-Study Proteomic and Bioinformatic Identification of Molecular Overlap between Amyotrophic Lateral Sclerosis (ALS) and Spinal Muscular Atrophy (SMA).

Authors:  Darija Šoltić; Melissa Bowerman; Joanne Stock; Hannah K Shorrock; Thomas H Gillingwater; Heidi R Fuller
Journal:  Brain Sci       Date:  2018-12-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.